Citation Impact
Citing Papers
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
2013
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
The Class I-Restricted Cytotoxic T Lymphocyte Response to Predetermined Epitopes in the Hepatitis B and C Viruses
1994
Hepatocellular carcinoma
2003 Standout
PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1
2004
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Src kinases involved in hepatitis B virus replication
1999
The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic Agents
1999
Control of cccDNA function in hepatitis B virus infection
2009
Hepatitis B Virus Polymerase Blocks Pattern Recognition Receptor Signaling via Interaction with DDX3: Implications for Immune Evasion
2010
Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance
2007
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Generation of improved humanized mouse models for human infectious diseases
2014
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Hepatitis C viral protein translation: mechanisms and implications in developing antivirals
2011
Two‐Photon Absorption and the Design of Two‐Photon Dyes
2009 Standout
New insight in the pathobiology of hepatitis B virus infection
2012
Animal models for the study of HBV replication and its variants
2005
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
2015
Drug-Induced Hepatotoxicity
2003 Standout
Hepatocellular carcinoma
2012 Standout
Hepatitis B virus infection
2009 Standout
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
2013
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks
2002
Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice
2015
Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donors
1996
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
CRL4s: the CUL4-RING E3 ubiquitin ligases
2009
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Molecular biology of the hepatitis B virus and role of the X gene
2010
Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
2014
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Five-Year Follow-up of Patients with Primary Antibody Deficiencies Following an Outbreak of Acute Hepatitis C
2001
Mechanisms of HBV-induced hepatocellular carcinoma
2016
Discovery of the hepatitis C virus
2009 StandoutNobel
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identification
1992 StandoutNobel
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA
1988
Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis
1996
Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting
1989 StandoutNatureNobel
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
2013
Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner
2010
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Persistent Hepatitis B Virus Infection in Subjects Without Hepatitis B Surface Antigen: Clinically Significant or Purely “Occult”?
2001
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B
1995
Infection in Solid-Organ Transplant Recipients
2007 Standout
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
2015 StandoutNobel
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
2012
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
2013
Replication of hepatitis C virus
2007 StandoutNobel
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
HBV Life Cycle: Entry and Morphogenesis
2009
PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization
2018
Hepatocellular Carcinoma
2019 Standout
Hepatitis B Virus Biology
2000
Patterns of nucleotide misincorporations during enzymatic amplification and direct large-scale sequencing of ancient DNA
2006 StandoutNobel
Hepatitis B Virus Encoded X Protein Suppresses Apoptosis by Inhibition of the Caspase-Independent Pathway
2012
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma
1996
Variability of hepatitis C virus
1995
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
1991 StandoutNobel
Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin
1994
Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex
2013 StandoutNobel
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
Subcellular Localization, Stability, and trans -Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines
2000 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
The agents of non-A, non-B viral hepatitis
1985
Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2013
Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide
1988
Highly Selective Wet Etch for High-Resolution Three-Dimensional Nanostructures in Arsenic Sulfide All-Inorganic Photoresist
2007
Hepatocarcinogenicity of the woodchuck hepatitis virus.
1987
Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand
2013
Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity
1993
Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns
2012
New Unnatural L-Nucleoside Enantiomers:From Their Stereospecific Synthesis to Their Biological Activities
1997
Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis
2013
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
1995 StandoutNobel
Transcription of woodchuck hepatitis virus in the chronically infected liver.
1985
Experimental non‐A, non‐B hepatitis in chimpanzees: Light, electron and immune microscopical observations
1983
Viruses in Human Cancers
1991 StandoutScienceNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3
2010
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins
1998 StandoutNobel
Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation
2007
The Chemistry of Neutron Capture Therapy
1998 Standout
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Detection of non-A, non-B hepatitis antigen by immunocytochemical staining.
1984
Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte
1994
In vivo models of hepatitis B and C virus infection
2016
Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips
2018
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Detection by immunofluorescence of an antigen‐antibody system in patients with acute and chronic non‐A, non‐B hepatitis
1981
Genetic organization and diversity of the hepatitis C virus.
1991 Standout
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus
2006
In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d -2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l -Arabinofuranosyluracil
2001
Works of O. Hantz being referenced
Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice
2011
Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction
1992
Control of Hepatitis B Virus Replication by Innate Response of Heparg Cells
2009
Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1
2008
Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro
2008
Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis
1992
The HepaRG Cell Line: Biological Properties and Relevance as a Tool for Cell Biology, Drug Metabolism, and Virology Studies
2010
Effects of 2′‐fluorinated arabinosyl‐pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks
1992
Detection of Polyadenylated RNA in Hepatitis B Virus-Infected Peripheral Blood Mononuclear Cells by Polymerase Chain Reaction
1991
Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates
2012
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
2016 Nature
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection
2011
Evolution of Hepatitis B Virus Polymerase Gene Sequence during Famciclovir Therapy for Chronic Hepatitis B
2000
Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells
2008
Phosphorylation of DHBV Pre-S: Identification of the Major Site of Phosphorylation and Effects of Mutations on the Virus Life Cycle
1998
HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase
2015
Immunopathologic aspects of woodchuck hepatitis.
1984
n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes
1996
Woodchuck hepatitis virus infection: Serologic and histopathologic course and outcome
1985
Detection by immunofluorescence of a new “core‐like” Ag/Ab system in liver and serum of patients with NANB hepatitis
1981
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
1996
Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases
1984
Potent Nonclassical Nucleoside Antiviral Drugs Based on the N,N-Diarylformamidine Concept
2004
NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULIN
1986
Antiviral Activity of β- l -2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus
2001
Heterogeneity of Hepatitis C Virus Genotypes in France
1994
Non‐A, non‐b hepatitis: identification of hepatitis‐b‐like virus particles in serum and liver
1980
Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l -5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model
2000
Maintenance of Woodchuck Hepatitis Virus Activity in Woodchuck Hepatocyte Primary Culture
1987
Non‐A, non‐b hepatitis virus: identification of a core antigen‐antibody system that cross reacts with hepatitis b core antigen and antibody
1981
Inhibitory Effect of Adefovir on Viral DNA Synthesis and Covalently Closed Circular DNA Formation in Duck Hepatitis B Virus-Infected Hepatocytes In Vivo and In Vitro
2002
Identification and detection of long incubation non-A, non-B hepatitis virus and associated antigens or antibodies
1980
Novel Alpha Interferon (IFN-α) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN-α2b Therapy in a Subgenomic Replicon System
2006
Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription
2013
Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector
2008